IPP Bureau
Amgen olpasiran may fill critical treatment gap in lowering Lp(a): GlobalData
By IPP Bureau - September 06, 2023
This study showed that patients taking 75mg of Olpasiran previously every 12 weeks presented a 40–50% reduction in LP(a)
Insmed announces positive results from Phase III arise study of ARIKAYCE
By IPP Bureau - September 06, 2023
Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
Apollo introduces India's first comprehensive Connected Care Services
By IPP Bureau - September 05, 2023
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
Cipla Medpro South Africa to acquire Actor Pharma
By IPP Bureau - September 05, 2023
This is a strategic acquisition for Cipla South Africa to unlock the future growth opportunities in the South African market
Caplin Steriles receives EIR from US FDA
By IPP Bureau - September 05, 2023
The inspection classification was determined by the agency as Voluntary Action Indicated
Neuroscientist Abhijeet Satani unveils Cognitively Operated System in Ahmedabad
By IPP Bureau - September 05, 2023
The cognitively operated system is a mother patent invention, first launched in India
Amgen settles with FTC over US$28 billion deal
By IPP Bureau - September 04, 2023
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
Shilpa Medicare receives UK MHRA approval for mouth-dissolving strips to treat illnesses
By IPP Bureau - September 03, 2023
This approval has come from the company's finished dosage form manufacturing facility
Zydus receives final USFDA approval for Erythromycin Tablets
By IPP Bureau - September 03, 2023
Erythromycin tablets is used to prevent and treat infections in many different parts of the body
BioNTech to lead $2 billion mRNA-based oncology therapy market despite challenges, says GlobalData
By IPP Bureau - September 03, 2023
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
Loop's health assurance model drives 200% YoY premium surge across 1000 companies
By IPP Bureau - September 02, 2023
Health Assurance is a unique healthcare model that combines health insurance with preventive healthcare with a focus on keeping people healthy while providing sick care for them when needed
India's digital startup ecosystem a catalyst for global healthcare transformation: Piyush Goyal
By IPP Bureau - September 02, 2023
Robots make it to the healthcare conference panel, reflecting the future potential of technology
USFDA delegation visits Amneal Pharmaceutical facility in Matoda
By IPP Bureau - September 02, 2023
Amneal’s site in Matoda is one of the company’s 12 pharmaceutical manufacturing facilities
Jupiter Life Line Hospitals’ IPO to open on Sept. 6
By IPP Bureau - September 02, 2023
Sets price band at ?695 to ?735 per Equity Share
